Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 150

Cited In for PubMed (Select 19502645)

1.

Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial.

Bittner V, Bertolet M, Barraza Felix R, Farkouh ME, Goldberg S, Ramanathan KB, Redmon JB, Sperling L, Rutter MK; BARI 2D Study Group.

J Am Coll Cardiol. 2015 Aug 18;66(7):765-73. doi: 10.1016/j.jacc.2015.06.019.

PMID:
26271057
2.

Effect of glycated hemoglobin on heart function of the patients with revascularization of coronary artery.

Sun XQ, Bao BN, Gao XY, Yan DE, Zhou YS.

Int J Clin Exp Pathol. 2015 Jun 1;8(6):7181-8. eCollection 2015.

3.

The Prevalence of Clinically Significant Ischemia in Patients Undergoing Percutaneous Coronary Intervention: A Report from the Multicenter Registry.

Fujita J, Kohsaka S, Ueda I, Inohara T, Maekawa Y, Kawamura A, Kanazawa H, Hayashida K, Tabei R, Tohyama S, Seki T, Suzuki M, Sano M, Fukuda K.

PLoS One. 2015 Jul 31;10(7):e0133568. doi: 10.1371/journal.pone.0133568. eCollection 2015.

4.

Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirements.

Yang F, Stewart M, Ye J, DeMets D.

Diabetes Metab Syndr Obes. 2015 Jul 20;8:315-25. doi: 10.2147/DMSO.S84005. eCollection 2015. Review.

5.

Comprehensive assessment of coronary fractional flow reserve.

Qi X, Fan G, Zhu D, Ma W, Yang C.

Arch Med Sci. 2015 Jun 19;11(3):483-93. doi: 10.5114/aoms.2015.52351.

6.

Revascularization in Severe Left Ventricular Dysfunction: Does Myocardial Viability Even Matter?

Singh P, Sethi N, Kaur N, Kozman H.

Clin Med Insights Cardiol. 2015 Jun 28;9(Suppl 1):105-9. doi: 10.4137/CMC.S18755. eCollection 2015. Review.

7.

Triglyceride High-Density Lipoprotein Ratios Predict Glycemia-Lowering in Response to Insulin Sensitizing Drugs in Type 2 Diabetes: A Post Hoc Analysis of the BARI 2D.

Zonszein J, Lombardero M, Ismail-Beigi F, Palumbo P, Foucher S, Groenewoud Y, Cushing G, Wajchenberg B, Genuth S; Bari 2d Study Group.

J Diabetes Res. 2015;2015:129891. doi: 10.1155/2015/129891. Epub 2015 May 27.

8.

Identification of coronary heart disease in asymptomatic individuals with diabetes mellitus: to screen or not to screen.

Bravo PE, Psaty BM, Di Carli MF, Branch KR.

Colomb Med (Cali). 2015 Mar 30;46(1):41-6. eCollection 2015 Jan-Mar. Review.

9.

Does ischemia burden in stable coronary artery disease effectively identify revascularization candidates? Ischemia burden in stable coronary artery disease does not effectively identify revascularization candidates.

Reynolds HR, Picard MH, Hochman JS.

Circ Cardiovasc Imaging. 2015 May;8(5):discussion p 9. doi: 10.1161/CIRCIMAGING.113.000362. No abstract available.

PMID:
25977302
10.

Management of Coronary Artery Calcium and Coronary CTA Findings.

Thomas DM, Divakaran S, Villines TC, Nasir K, Shah NR, Slim AM, Blankstein R, Cheezum MK.

Curr Cardiovasc Imaging Rep. 2015;8(6):18. Review.

11.

Coronary artery disease in type 2 diabetes mellitus: Recent treatment strategies and future perspectives.

Naito R, Kasai T.

World J Cardiol. 2015 Mar 26;7(3):119-24. doi: 10.4330/wjc.v7.i3.119.

12.

Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes.

Nolan CJ, Ruderman NB, Kahn SE, Pedersen O, Prentki M.

Diabetes. 2015 Mar;64(3):673-86. doi: 10.2337/db14-0694. Review.

13.

Conservative strategy for treatment of stable coronary artery disease.

Rezende PC, Scudeler TL, da Costa LM, Hueb W.

World J Clin Cases. 2015 Feb 16;3(2):163-70. doi: 10.12998/wjcc.v3.i2.163. Review.

14.

Fractional flow reserve versus angiography for guiding percutaneous coronary intervention: a meta-analysis.

Zhang D, Lv S, Song X, Yuan F, Xu F, Zhang M, Yan S, Cao X.

Heart. 2015 Mar;101(6):455-62. doi: 10.1136/heartjnl-2014-306578. Epub 2015 Jan 30.

15.

Effectiveness of biomarkers in cardiology.

Correia LC.

Arq Bras Cardiol. 2014 Dec;103(6):449-50. doi: 10.5935/abc.20140194. English, Portuguese. No abstract available.

16.

Appropriate revascularization in stable angina: lessons from the BARI 2D trial.

Krone RJ, Althouse AD, Tamis-Holland J, Venkitachalam L, Campos A, Forker A, Jacobs AK, Ocampo S, Steiner G, Fuentes F, Pena Sing IR, Brooks MM; BARI 2D Study Group.

Can J Cardiol. 2014 Dec;30(12):1595-601. doi: 10.1016/j.cjca.2014.07.748. Epub 2014 Aug 20.

PMID:
25475464
17.

Pediatric lipid management: an earlier approach.

Zachariah JP, Johnson PK.

Endocrinol Metab Clin North Am. 2014 Dec;43(4):981-92. doi: 10.1016/j.ecl.2014.08.004. Review.

PMID:
25432392
18.

Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization.

Taqueti VR, Hachamovitch R, Murthy VL, Naya M, Foster CR, Hainer J, Dorbala S, Blankstein R, Di Carli MF.

Circulation. 2015 Jan 6;131(1):19-27. doi: 10.1161/CIRCULATIONAHA.114.011939. Epub 2014 Nov 16.

PMID:
25400060
19.
20.

Estimated insulin sensitivity predicts regression of albuminuria in Type 1 diabetes.

Bjornstad P, Maahs DM, Johnson RJ, Rewers M, Snell-Bergeon JK.

Diabet Med. 2015 Feb;32(2):257-61. doi: 10.1111/dme.12572. Epub 2014 Oct 10.

PMID:
25303233
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk